Integrium, LLC Launches Newly Revamped Company Website

Tustin, CA – Integrium, LLC, a full-service Clinical Proof of Concept (PoC) Firm, announced today the launch of its newly revamped company website. This updated website offers quick and easy navigation throughout the company’s portals of clinical trial therapeutic experience and key CRO services with detailed information. With easy access to assistance for prospective clients interested in partnerships, availability for tips, guidance or advice from our founders and key leadership, the new website allows users to gain all answers to their questions with just a few clicks.

The new website has a sleek look with enriched content developed from recent years of success, met goals, new clientele and relationships, gained therapeutic expertise, and beyond. Integrium, LLC hopes the launch of the new website will provide viewers with enough information to stay updated on our services, experience, and recent events and lead them to contacting us for collaboration or potential relationships.

"We are excited regarding the new look and feel of the Integrium website. We pride ourselves on giving our clients full access to our capital raising partners, clinical development expertise, and all other contacts within our biotech ecosystem," mentioned Mike Loftus, Executive Director of Business Development.

Integrium’s new site will continuously be updated with current events about clinical trials and projects we are involved in, future events we will attend, blogs related to our expertise, and new product information. Integrium encourages website visitors to contact us using our messaging portal or direct phone number for feedback on the website or any requested information about our products and services. On behalf of everyone at Integrium, LLC, we hope you enjoy our new website!

About Integrium

Through a trusted partnership with Proof of Concept (PoC) Capital, Integrium is able to assist Micro Cap, Small Cap, and Privately held Biotechs looking to raise additional financing, by providing new clinical data to create the next bump in valuation. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.


To learn more about Integrium Clinical Research, please contact:

Mike Loftus
Executive Director, Business Development
Phone: (908) 295-4578

Emily MacHale
Associate Director, Marketing & Research
Phone: 908-375-2009

Click to Register